Evidence map›Paper›PMID 31240131›Full record

ArticleCell death discovery2019

A six-inhibitor culture medium for improving naïve-type pluripotency of porcine pluripotent stem cells.

Ye Yuan, Jinkyu Park, Yuchen Tian, Jungmin Choi, Rolando Pasquariello, Andrei P Alexenko, Aihua Dai, Susanta K Behura, R Michael Roberts, Toshihiko Ezashi

Open access · goldAbstract read
In one paragraph

Article in Cell death discovery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. The role of BMP4 signaling in trophoblast emergence from pluripotency.Cellular and molecular life sciences : CMLS · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Ye Yuan *1Bond Life Sciences Center, University of Missouri, Columbia, MO 65211 USA.
Jinkyu Park *1Bond Life Sciences Center, University of Missouri, Columbia, MO 65211 USA.
Yuchen Tian1Bond Life Sciences Center, University of Missouri, Columbia, MO 65211 USA.
Jungmin Choi5Laboratory of Human Genetics and Genomics, The Rockefeller University, New York, NY 10065 USA.
Rolando Pasquariello3Colorado Center for Reproductive Medicine, Lone Tree, CO 80124 USA.ORCID 0000-0003-3191-7009
Andrei P Alexenko1Bond Life Sciences Center, University of Missouri, Columbia, MO 65211 USA.
Aihua Dai1Bond Life Sciences Center, University of Missouri, Columbia, MO 65211 USA.
Susanta K Behura2Division of Animal Sciences, University of Missouri, Columbia, MO 65211 USA.
R Michael Roberts1Bond Life Sciences Center, University of Missouri, Columbia, MO 65211 USA.
Toshihiko Ezashi1Bond Life Sciences Center, University of Missouri, Columbia, MO 65211 USA.ORCID 0000-0001-6955-8449
University of Missouri · USColorado Center for Reproductive Medicine · USRockefeller University · USUniversity of Milan · ITYale University · US

Funding

Induced Pluripotent Stem Cells from Swine: application to genetic modificationR01HD069979 · NICHD · UNIVERSITY OF MISSOURI-COLUMBIA · PI ROBERTS, R. MICHAEL · 2012 to 2016
$1.5M
Maintenance of Stem Cell Pluripotency in Pigs with Interleukin-6R21OD026516 · OD · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI EALY, ALAN D · 2018 to 2019
$450k
NICHD NIH HHS R01 HD069979NIH HHS R21 OD026516
6 · The paper itself

Abstract

Understanding essential signaling network requirements and making appropriate adjustments in culture conditions are crucial if porcine pluripotent stem cells (PSC) are to achieve their full potential. Here, we first used two protein factors (LIF and FGF2) and kinase inhibitor combinations in attempts to convert primed type lentiviral-reprogrammed porcine induced PSC (Lv-piPSC) into naïve-like state and developed a medium called FL6i. In addition to FGF2 and LIF, this medium contained inhibitors of MAPK14, MAPK8, TGFB1, MAP2K1, GSK3A and BMP. Crucially, the usual TGFB1 and BMP4 protein components of many stem cell media were replaced in FL6i with inhibitors of TGFB1 and BMP. With this medium, Lv-piPSC were readily transformed from their original primed state into cells that formed colonies with typical features of naïve-state stem cells. The FL6i medium also assisted generation of naïve-type piPSC lines from porcine embryonic fibroblasts with non-integrating episomal plasmids (Epi-piPSC). These lines, despite retaining variable amounts of vector DNA, expressed higher endogenous

Identifiers

PMID31240131
PMCPMC6579764
OpenAlexW2951865712

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.